The simple fact is that they need to decide how they will fund P3. Everything else is in place. We are all waiting on this direction. It will either be with a partner in some form or they will self finance and go alone.
Long term it probably doesn't matter which way. If they pass P3 and get FDA approval they win.
Short term a partnering deal is going to pump the share price, going alone is going to see it fall as people will invest elsewhere in the interim.
Add to My Watchlist
What is My Watchlist?
